Deep Longevity Appoints U.S. Leadership Ahead of 2026 Commercial Launch
I'm PortAI, I can summarize articles.
Deep Longevity, a subsidiary of Regent Pacific Group, announces its U.S. expansion and key leadership appointments in preparation for its commercial launch in 2026. This strategic move aims to strengthen its presence in the U.S. market. The announcement was originally published by Regent Pacific Group Ltd. via the Hong Kong Stock Exchange's Issuer Information Service.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments